WallStreetZenWallStreetZen

NYSE: DHR
Danaher Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for DHR

Based on 10 analysts offering 12 month price targets for Danaher Corp

Min Forecast
$212.00+18.45%
Avg Forecast
$242.70+35.6%
Max Forecast
$275.00+53.65%

Should I buy or sell DHR stock?

Based on 10 analysts offering ratings for Danaher Corp.

Strong Buy
Strong Buy
7 analysts 70%
Buy
2 analysts 20%
Hold
1 analysts 10%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although DHR's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates DHR as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their DHR stock forecasts and price targets.

DHR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-23
lockedlocked$00.00+00.00%2026-04-22
lockedlocked$00.00+00.00%2026-04-22
lockedlocked$00.00+00.00%2026-04-22
lockedlocked$00.00+00.00%2026-04-22
Barclays
Bottom 3%
3
Strong BuyMaintains$230.00+28.51%2026-04-14
Goldman Sachs
Bottom 20%
20
Strong BuyMaintains$230.00+28.51%2026-04-13
Evercore ISI Group
Bottom 5%
5
BuyMaintains$225.00+25.71%2026-04-06
JP Morgan
Top 18%
83
Strong BuyMaintains$275.00+53.65%2026-01-29
TD Cowen
Top 7%
94
Strong BuyMaintains$270.00+50.85%2026-01-07Find out why

1 of 1

Forecast return on equity

Is DHR forecast to generate an efficient return?

Company
15.06%
Industry
-203.49%
Market
174.65%
DHR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is DHR forecast to generate an efficient return on assets?

Company
9.55%
Industry
16.95%
DHR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

DHR earnings per share forecast

What is DHR's earnings per share in the next 3 years based on estimates from 27 analysts?

Avg 1 year Forecast
$8.49+63.62%
Avg 2 year Forecast
$9.21+77.38%
Avg 3 year Forecast
$10.17+95.97%
DHR's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

DHR revenue forecast

What is DHR's revenue in the next 3 years based on estimates from 27 analysts?

Avg 1 year Forecast
$25.9B+4.54%
Avg 2 year Forecast
$27.4B+10.54%
Avg 3 year Forecast
$29.3B+18.18%
DHR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DHR earnings growth forecast

How is DHR forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
24.91%
Industry
18.19%
Market
35.62%
DHR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
DHR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
DHR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

DHR revenue growth forecast

How is DHR forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
5.61%
Industry
8.43%
Market
14.21%
DHR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DHR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DHR vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
DHR$178.98$242.70+35.60%Strong Buy
TMO$470.22$655.58+39.42%Strong Buy
IDXX$568.30$736.88+29.66%Strong Buy
A$114.87$164.33+43.06%Strong Buy
WAT$300.73$386.82+28.63%Buy
View Top Diagnostic & Research Stocks

Danaher Stock Forecast FAQ

Is Danaher Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NYSE: DHR) stock is to Strong Buy DHR stock.

Out of 10 analysts, 7 (70%) are recommending DHR as a Strong Buy, 2 (20%) are recommending DHR as a Buy, 1 (10%) are recommending DHR as a Hold, 0 (0%) are recommending DHR as a Sell, and 0 (0%) are recommending DHR as a Strong Sell.

If you're new to stock investing, here's how to buy Danaher stock.

What is DHR's earnings growth forecast for 2026-2028?

(NYSE: DHR) Danaher's forecast annual earnings growth rate of 24.91% is forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 18.19%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.62%.

Danaher's earnings in 2026 is $3,689,000,000.On average, 27 Wall Street analysts forecast DHR's earnings for 2026 to be $6,010,458,942, with the lowest DHR earnings forecast at $5,791,687,041, and the highest DHR earnings forecast at $6,324,284,438. On average, 26 Wall Street analysts forecast DHR's earnings for 2027 to be $6,515,665,615, with the lowest DHR earnings forecast at $6,228,664,626, and the highest DHR earnings forecast at $7,000,559,272.

In 2028, DHR is forecast to generate $7,198,451,939 in earnings, with the lowest earnings forecast at $6,755,812,189 and the highest earnings forecast at $7,855,192,304.

What is DHR's revenue growth forecast for 2026-2028?

(NYSE: DHR) Danaher's forecast annual revenue growth rate of 5.61% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.21%.

Danaher's revenue in 2026 is $24,778,000,000.On average, 27 Wall Street analysts forecast DHR's revenue for 2026 to be $18,333,382,551,181, with the lowest DHR revenue forecast at $17,688,603,509,984, and the highest DHR revenue forecast at $19,523,144,975,168. On average, 27 Wall Street analysts forecast DHR's revenue for 2027 to be $19,385,129,702,903, with the lowest DHR revenue forecast at $18,484,845,465,359, and the highest DHR revenue forecast at $21,773,147,798,401.

In 2028, DHR is forecast to generate $20,725,647,270,441 in revenue, with the lowest revenue forecast at $19,378,759,767,260 and the highest revenue forecast at $23,781,093,067,200.

What is DHR's forecast return on assets (ROA) for 2026-2029?

(NYSE: DHR) forecast ROA is 9.55%, which is lower than the forecast US Diagnostics & Research industry average of 16.95%.

What is DHR's Price Target?

According to 10 Wall Street analysts that have issued a 1 year DHR price target, the average DHR price target is $242.70, with the highest DHR stock price forecast at $275.00 and the lowest DHR stock price forecast at $212.00.

On average, Wall Street analysts predict that Danaher's share price could reach $242.70 by Apr 23, 2027. The average Danaher stock price prediction forecasts a potential upside of 35.6% from the current DHR share price of $178.98.

What is DHR's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: DHR) Danaher's current Earnings Per Share (EPS) is $5.19. On average, analysts forecast that DHR's EPS will be $8.49 for 2026, with the lowest EPS forecast at $8.18, and the highest EPS forecast at $8.94. On average, analysts forecast that DHR's EPS will be $9.21 for 2027, with the lowest EPS forecast at $8.80, and the highest EPS forecast at $9.89. In 2028, DHR's EPS is forecast to hit $10.17 (min: $9.55, max: $11.10).

What is DHR's forecast return on equity (ROE) for 2026-2029?

(NYSE: DHR) forecast ROE is 15.06%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.